Literature DB >> 28280998

Virulence factors of fluconazole-susceptible and fluconazole-resistant Candida albicans after antimicrobial photodynamic therapy.

Fernanda Alves1, Ewerton Garcia de Oliveira Mima1, Renata Caroline Polato Passador1, Vanderlei Salvador Bagnato2, Janaína Habib Jorge1, Ana Cláudia Pavarina3.   

Abstract

This study evaluated the effects of antimicrobial photodynamic therapy (aPDT) mediated by Photodithazine® (PDZ) and LED light on the virulence factors of fluconazole-susceptible (CaS) and fluconazole-resistant (CaR) Candida albicans. Standardized suspensions of strains were prepared (107), and after 48 h of biofilm formation, these strains were incubated with PDZ (100 mg/L) for 20 min and exposed to LED light (660 nm, 37.5 J/cm2). Additional samples were treated with PDZ or light only, and the control consisted of biofilms that received no treatment. After aPDT, the cells were recovered and the virulence factors were evaluated. To analyze the capacity of adhesion, cells were recovered after aPDT and submitted to the adhesion process in the bottom of a 96-well plate. After this, metabolic activity tests (XTT assay) and cell viability (colony forming units per milliliter, CFU/mL) were applied. To evaluate the biofilm-forming ability after aPDT, the cells recovered were submitted to biofilm formation procedures, and the biofilm formed was evaluated by XTT, CFU/mL, and total biomass (crystal violet) tests. Lastly, the capacity for synthesizing protease and phospholipase enzymes after aPDT was evaluated by fluorimetric tests. Data were analyzed by two- or three-way ANOVA tests (p ≤ 0.05). It was verified that aPDT reduced the viability of both strains, fluconazole-susceptible and fluconazole-resistant C. albicans. It was also observed that the CaR strain had lower susceptibility to the aPDT when compared with the CaS strain. However, regarding the virulence factors evaluated, it was demonstrated that aPDT did not alter the adherence and biofilm formation ability and enzymatic production.

Entities:  

Keywords:  Candida albicans; Drug resistance; Photodynamic inactivation; Virulence factors

Mesh:

Substances:

Year:  2017        PMID: 28280998     DOI: 10.1007/s10103-017-2177-y

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  39 in total

Review 1.  Oral candidosis.

Authors:  C S Farah; R B Ashman; S J Challacombe
Journal:  Clin Dermatol       Date:  2000 Sep-Oct       Impact factor: 3.541

2.  Photodynamic antimicrobial chemotherapy (PACT) inhibits biofilm formation by Candida albicans, increasing both ROS production and membrane permeability.

Authors:  Isabela Bueno Rosseti; Luciene Reginato Chagas; Maricilia Silva Costa
Journal:  Lasers Med Sci       Date:  2013-11-01       Impact factor: 3.161

3.  Fungicidal effect of photodynamic therapy against fluconazole-resistant Candida albicans and Candida glabrata.

Authors:  Lívia Nordi Dovigo; Ana Cláudia Pavarina; Ewerton Garcia de Oliveira Mima; Eunice Teresinha Giampaolo; Carlos Eduardo Vergani; Vanderlei Salvador Bagnato
Journal:  Mycoses       Date:  2011-03       Impact factor: 4.377

Review 4.  Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.

Authors:  T C White; K A Marr; R A Bowden
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

Review 5.  Colonization of Candida species in denture wearers with emphasis on HIV infection: a literature review.

Authors:  Leticia F Perezous; Catherine M Flaitz; Millicent E Goldschmidt; Robert L Engelmeier
Journal:  J Prosthet Dent       Date:  2005-03       Impact factor: 3.426

6.  Antimicrobial photodynamic therapy in rat experimental candidiasis: evaluation of pathogenicity factors of Candida albicans.

Authors:  Joyce da Silva Martins; Juliana Campos Junqueira; Raquel Lourdes Faria; Naiara Fonseca Santiago; Rodnei Dennis Rossoni; Carlos Eduardo Dias Colombo; Antonio Olavo Cardoso Jorge
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2011-01

7.  Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance.

Authors:  J Chandra; D M Kuhn; P K Mukherjee; L L Hoyer; T McCormick; M A Ghannoum
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

8.  Evaluation of gene expression SAP5, LIP9, and PLB2 of Candida albicans biofilms after photodynamic inactivation.

Authors:  Fernanda Freire; Patrícia Pimentel de Barros; Damara da Silva Ávila; Graziella Nuernberg Back Brito; Juliana Campos Junqueira; Antonio Olavo Cardoso Jorge
Journal:  Lasers Med Sci       Date:  2015-04-28       Impact factor: 3.161

9.  Characterization of biofilms in drug-sensitive and drug-resistant strains of Candida albicans.

Authors:  Elisabetta Vavala; Marisa Colone; Claudio Passariello; Ignacio Celestino; Laura Toccacieli; Annarita Stringaro; Letizia Angiolella
Journal:  J Chemother       Date:  2013-04       Impact factor: 1.714

10.  The use of Chitosan to enhance photodynamic inactivation against Candida albicans and its drug-resistant clinical isolates.

Authors:  Hsiung-Fei Chien; Chueh-Pin Chen; Yee-Chun Chen; Po-Han Chang; Tsuimin Tsai; Chin-Tin Chen
Journal:  Int J Mol Sci       Date:  2013-04-03       Impact factor: 5.923

View more
  3 in total

1.  Virulence Factors in Candida albicans and Streptococcus mutans Biofilms Mediated by Farnesol.

Authors:  Renan Aparecido Fernandes; Douglas Roberto Monteiro; Laís Salomão Arias; Gabriela Lopes Fernandes; Alberto Carlos Botazzo Delbem; Debora Barros Barbosa
Journal:  Indian J Microbiol       Date:  2018-02-22       Impact factor: 2.461

2.  Curcumin-mediated anti-microbial photodynamic therapy against Candida dubliniensis biofilms.

Authors:  Paula Volpato Sanitá; Ana Cláudia Pavarina; Lívia Nordi Dovigo; Ana Paula Dias Ribeiro; Mariana Carvalho Andrade; Ewerton Garcia de Oliveira Mima
Journal:  Lasers Med Sci       Date:  2017-11-13       Impact factor: 3.161

Review 3.  Antimicrobial Photodynamic Therapy to Control Clinically Relevant Biofilm Infections.

Authors:  Xiaoqing Hu; Ying-Ying Huang; Yuguang Wang; Xiaoyuan Wang; Michael R Hamblin
Journal:  Front Microbiol       Date:  2018-06-27       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.